EUVIMEDEUVIMED entdecken
CrossrefInfokarte

Prognostic value of the red cell distribution width-to-high-density lipoprotein cholesterol ratio in acute coronary syndrome

Muhammad Haris Ramadhan, Adi Purnawarman, B Buchari, Maha Fitra, N Novita, Muhammad Riswan

Romanian Medical Journal · 2026-09-30 · 73 (3) · 372

DOI: 10.37897/rmj.2026.3.13 ↗
AbstractBibliografische Angaben

Abstract

Background and objectives. Risk stratification in patients with acute coronary syndrome (ACS) remains challenging, particularly in clinical settings where conservative management without revascularization is the primary treatment pathway. This study evaluated the prognostic utility of the red cell distribution width-to-high-density lipoprotein cholesterol ratio (RHR), red cell distribution width (RDW), and high-density lipoprotein cholesterol (HDL-C) in assessing outcomes among ACS patients managed conservatively. Materials and methods. A prospective cohort study was conducted between July and October 2024 at a tertiary referral hospital in Banda Aceh, Indonesia. Eighty-two ACS patients managed without revascularization were followed for three months to ascertain the development of major adverse cardiovascular events (MACE). Baseline RDW and lipid profiles were obtained to calculate RHR. Predictive performance was assessed using receiver operating characteristic (ROC) curves, and adjusted associations were examined using multivariable logistic regression. Results. MACE occurred in 47.6% (n = 39) of the cohort. An RHR cut-off of ≥0.375 demonstrated a moderate discriminatory area under the curve (AUC = 0.699). In unadjusted bivariate analysis, both elevated RHR and low HDL-C (

Wissen, das zu Ihrer Arbeit passt.

Vom kostenlosen Einstieg über die persönliche Recherche bis zur vollständigen Research Suite.

Tarife ansehen →

Sind alle Verlagsvolltexte enthalten?

Nein. Bibliografische Nachweise, Abstracts und Volltexte sind unterschiedliche Inhalte. Ob ein Volltext verfügbar ist, hängt von der Quelle, Open Access und Ihren vorhandenen Lizenzen ab. Ein EUVIMED-Tarif ersetzt keine zusätzlichen Verlagsrechte.

Tarife ansehen →